We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.4B
AUM Growth
+$3.53B
(+32%)
Cap. Flow
+$2.81B
Cap. Flow
% of AUM
19.5%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
1,820
New
468
Increased
1,221
Reduced
109
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$160M |
| 2 |
Microsoft
MSFT
|
+$116M |
| 3 |
Amazon
AMZN
|
+$84.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$71.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$57.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$62.3M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
+$6.62M |
| 3 |
VF Corp
VFC
|
+$4.38M |
| 4 |
W.W. Grainger
GWW
|
+$3.97M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$3.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.64% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 13.98% |
| 4 | Consumer Staples | 10.45% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Charles River Laboratories
CRL
$10.9B
| $587K | ﹤0.01% |
5,367
+1,201
| +29% | +$131K |
|
1052
Assured Guaranty
AGO
$3.78B
| $585K | ﹤0.01% |
17,278
+759
| +5% | +$27.5K |
|
|
ARRS
1053
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $585K | ﹤0.01% |
22,769
+5,465
| +32% | +$154K |
|
1054
ICU Medical
ICUI
$3.93B
| $582K | ﹤0.01% |
2,693
+1,367
| +103% | +$277K |
|
|
AMRN
1055
Amarin Corp
AMRN
$284M
| $581K | ﹤0.01% |
7,241
-190
| -3% | -$13.1K |
|
|
BWLD
1056
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $580K | ﹤0.01% |
3,711
+1,587
| +75% | +$209K |
|
|
BOLD
1057
DELISTED
Audentes Therapeutics, Inc
BOLD
| $579K | ﹤0.01% |
18,521
+1,823
| +11% | +$50.1K |
|
|
ELLI
1058
DELISTED
Ellie Mae Inc
ELLI
| $579K | ﹤0.01% |
6,477
+2,998
| +86% | +$265K |
|
1059
Westlake Corp
WLK
$9.46B
| $577K | ﹤0.01% |
5,413
-35
| -0.6% | -$3.24K |
|
1060
Cars.com
CARS
$641M
| $576K | ﹤0.01% |
19,959
+7,954
| +66% | +$206K |
|
1061
MillerKnoll
MLKN
$1.5B
| $576K | ﹤0.01% |
14,393
+6,275
| +77% | +$220K |
|
1062
PetMed Express
PETS
$42.5M
| $576K | ﹤0.01% |
+12,665
| New | +$499K |
|
|
BIG
1063
DELISTED
Big Lots, Inc.
BIG
| $576K | ﹤0.01% |
10,256
+4,113
| +67% | +$223K |
|
|
CPE
1064
DELISTED
Callon Petroleum Company
CPE
| $575K | ﹤0.01% |
4,736
+2,069
| +78% | +$229K |
|
|
EFOR
1065
Everforth Inc
EFOR
$845M
| $573K | ﹤0.01% |
8,914
+4,456
| +100% | +$270K |
|
1066
Trex
TREX
$4.51B
| $572K | ﹤0.01% |
21,124
+10,700
| +103% | +$272K |
|
1067
Pediatrix Medical
MD
$2.16B
| $570K | ﹤0.01% |
10,675
+2,411
| +29% | +$114K |
|
1068
Avanos Medical
AVNS
$1.17B
| $566K | ﹤0.01% |
12,246
+4,932
| +67% | +$227K |
|
1069
LCI Industries
LCII
$2.51B
| $566K | ﹤0.01% |
4,357
+2,203
| +102% | +$271K |
|
1070
Travere Therapeutics
TVTX
$5.33B
| $566K | ﹤0.01% |
26,852
+2,603
| +11% | +$59.5K |
|
1071
Columbia Banking Systems
COLB
$8.81B
| $562K | ﹤0.01% |
12,932
+7,792
| +152% | +$340K |
|
|
AHL
1072
DELISTED
ASPEN Insurance Holding Limited
AHL
| $562K | ﹤0.01% |
13,852
+1,754
| +14% | +$72.5K |
|
1073
FirstCash
FCFS
$8.55B
| $561K | ﹤0.01% |
8,319
+4,127
| +98% | +$267K |
|
1074
Nutanix
NTNX
$14.9B
| $561K | ﹤0.01% |
+15,915
| New | +$482K |
|
|
ATH
1075
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $561K | ﹤0.01% |
10,848
+689
| +7% | +$35.2K |
|
Similar funds
ProShare Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, ProShare Advisors held 1,820 positions worth $14.4B, up 32% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors deployed $2.81B of net new capital in Q4 2017, opening 468 new positions and adding to 1,221 existing holdings. Its largest new stake was ASML: 31,220 shares worth $5.43M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VF Corp, an estimated $4.38M trimmed.
- ProShare Advisors's largest Q4 2017 buy was ASML: 31,220 shares worth $5.43M.
- ProShare Advisors added most to Apple in Q4 2017, an estimated $160M increase.
- ProShare Advisors's biggest Q4 2017 reduction was VF Corp, cutting an estimated $4.38M.
- ProShare Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.3M.
- ProShare Advisors's ten largest holdings make up 18% of its $14.4B portfolio in Q4 2017.
- ProShare Advisors opened 468 new positions and closed 21 in Q4 2017.
- ProShare Advisors's portfolio value rose 32% quarter-over-quarter to $14.4B.
Based on ProShare Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.